Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Promomed's revenues for 9 months increased by 34%

12/2/24 PRMD

Future Vending has opened a round of investment attraction

12/2/24 OTCI

Rosneft's hydrocarbon production for 9 months amounted to 193.4 mln tons of oil equivalent

12/2/24 ROSN

Rosneft reported for 9 months of 2024 by IFRS

12/2/24 ROSN

Bashneft reports for 9 months of 2024 by RAS

12/2/24 BANE

Rosneft reports for 9 months of 2024 by RAS

12/2/24 ROSN

Gazprom reported for 9 months of 2024 by IFRS

12/2/24 GAZP

Shareholders of Mordovian Energy Supply Company approved dividends

11/29/24 MRSB

Aeroflot earned almost 60 billion rubles in 9 months of 2024

11/29/24 AFLT

Transneft wants to raise the tariff for oil pumping by 8.7%%

11/29/24 TRNFP